Strategy
Classification, pathway, and evidence planning that makes the next decision clearer.
Explore strategy →REGULATORY · CLINICAL · QUALITY
A clearer path through complex device regulation.
Qualira aligns strategy, clinical evidence, and quality systems before uncertainty becomes cost and delay.
Strategy, evidence, and quality aligned before submission.
30+ yearsregulatory leadership
Former BSIassessor experience
FDA + globalpathways
Seniorspecialists
WHERE THE DECISION CHANGES
Make the right decision earlier.
One connected team for the hard parts of device development.
Submissions
Pre-submissions through product submissions, built for complete and coherent review.
Explore submissions →Clinical + quality
Clinical programs and quality systems that can stand up to scrutiny.
Explore clinical + quality →Case outcome
Clinical evidence strategyA clinical-trial plan became a De Novo path supported by animal data.
Qualira helped a novel-device team reframe its FDA engagement before a more costly path took hold.
WHAT QUALIRA CONNECTS
From first classification question through post-clearance and/or approval requirements.
- 01
Orient
Understand the device, intended use, risk, evidence, and markets before deciding what to build.
- 02
Position
Set a regulatory and clinical strategy that fits the program rather than forcing the program into a default.
- 03
Deliver
Advance submissions, clinical studies, quality systems, and remediation with hands-on team support.
REAL PROGRAMS. REAL PRESSURE.
When the original plan is not the best path.
Explore the anonymous client stories that show how Qualira applies regulatory, clinical, and quality expertise when the stakes are high.
View success stories →510(k)De NovoPMAEU MDRQMSClinical
START WITH THE DECISION IN FRONT OF YOU